Institutional Review Board (IRB)

Research and Development Solutions IRB

Research and Development Solutions (RADS) is registered under Office for Human Research Protection (OHRP) and has been formally designated to review, approve and monitor biomedical and behavioral research. We review health, employment, social and demographics research that involve human subjects.
The primary function or role of the IRB is to safeguard human subjects by training researchers in research ethics and best practices and reviewing research proposals. In reviewing a research protocol, the IRB balances the research’s risk to the human subjects with the benefits to society

Purpose:

The primary purpose of the IRB is to protect the rights and welfare of human subjects involved in research activities and look at proposed scientific methods to ensure the highest quality research.

Our Goals:

  • To promote the safety and well-being of human participants.
  • To ensure adherence to the ethical values and principles underlying research.
  • To ensure that only ethical and scientifically valid research is implemented.
  • To allay concerns of the general public about the responsible conduct of research.

Responsibilities

We are responsible for encouraging research activities to benefit the advancement of knowledge of human conditions. At the same time, we assume responsibility for ensuring the conditions for protecting human subjects as required by the National Research Act, Public Law 93- 348 and implemented by U.S. Department of Health and Human Services (DHHS). We require that information given to participants as part of informed consent is in accordance with appropriate laws, regulations, and international standards. The IRB may require that additional information be given to the participants when, in the IRB’s judgment, the information would meaningfully add to the protection of the rights and welfare of participants

Why RADS?

We have the professional competence necessary to review the specific research activities presented. We have an effective knowledge of subject populations and other factors that can foreseeably contribute to the determination of a risk-benefit ratio to subjects and subjects’ informed consent. We are able to judge the adequacy and accuracy of the information on the informed consent document, advertising, and other materials distributed to the subjects.

Decision Making:

Based on the IRB’s recommendation, the applicant may expect the following results:

  1. Approved: Approval is granted with no revisions necessary.
  2. Approved subject to required modifications: If minor changes or clarifications are needed, the IRB Chairperson overseeing the application may approve the research on behalf of the Committee once the revisions are completed. In this case, the applicant will have 4 weeks to provide additional information/ revisions required.
  3. Non-approval or disapproval: when a proposal does not fit the required standards, it will be disapproved. Disapproval results when the IRB has determined the protocol has risks that outweigh the benefits of participation and/or the application is significantly deficient in other areas. The application may be re-submitted only after complete revision.

IRB Chair Person

Mr. Hasan Rizvi

IRB Coordinator

Ms. Asmita Bano

IRB Secretariate

Ms. Annan Saeed

Internal Members

Dr. Ayesha Khan
Dr. Adnan Khan
Ms. Shazia Naseer
Mr. Inaam ul Haq
Mr. Kaleem Ullah
Mr. Abdul Mueed
Ms. Rafia Amir
Ms. Khadeeja Ahmed
Ms. Nafia Nawaz
Ms. Amna Syed
Mr. Moheeb Abassi
Mr. Adeel Hasan Jalali
Mr. Ibtisam Sajjad
Mr. Maisam Khan
Mr. Sohaib Aqib

 

External Advisors/External Members

Ms. Huma Chughtai
Dr. Umbreen Salim
Dr. Nashmia Mahmood
Dr. Khurram Azmat
Dr. Usman Siddique
Ms. Syeda Yumna
Ms. Sidra Khalid